CorMedix (CRMD) Accumulated Expenses (2010 - 2025)

CorMedix has disclosed Accumulated Expenses across 15 years of filings, most recently posting $2.3 million for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $2.3 million, down 92.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (down 92.7% YoY), and the FY2025 annual result was $2.3 million, down 92.7% from the prior year.
• Accumulated Expenses came in at $2.3 million for Q4 2025 at CorMedix, down from $109.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $109.1 million in Q3 2025 to a low of $1.0 million in Q1 2021.
• The 5-year median for Accumulated Expenses is $3.5 million (2024), against an average of $11.1 million.
• Peak annual rise in Accumulated Expenses reached 2178.19% in 2025, while the deepest fall reached 92.7% in 2025.
• CorMedix's Accumulated Expenses stood at $3.0 million in 2021, then soared by 31.84% to $4.0 million in 2022, then slumped by 31.59% to $2.7 million in 2023, then soared by 1075.24% to $32.0 million in 2024, then tumbled by 92.7% to $2.3 million in 2025.
• The last three Accumulated Expenses figures came in at $2.3 million (Q4 2025), $109.1 million (Q3 2025), and $3.6 million (Q2 2025), per Business Quant data.